Establishment Deferred Long Term Liab vs Accounts Payable Analysis

ESTA Stock

USD 43.08 0.47 1.10%

Establishment Labs financial indicator trend analysis is much more than just examining Establishment Labs latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Establishment Labs is a good investment. Please check the relationship between Establishment Labs Deferred Long Term Liab and its Accounts Payable accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Deferred Long Term Liab vs Accounts Payable

Deferred Long Term Liab vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Establishment Labs Deferred Long Term Liab account and Accounts Payable. At this time, the significance of the direction appears to have pay attention.

The correlation between Establishment Labs' Deferred Long Term Liab and Accounts Payable is -0.91. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Establishment Labs Holdings, assuming nothing else is changed. The correlation between historical values of Establishment Labs' Deferred Long Term Liab and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Establishment Labs Holdings are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Deferred Long Term Liab i.e., Establishment Labs' Deferred Long Term Liab and Accounts Payable go up and down completely randomly.

Correlation Coefficient

-0.91

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Accounts Payable

An accounting item on the balance sheet that represents Establishment Labs obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Establishment Labs are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from Establishment Labs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Establishment Labs current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

The current year's Tax Provision is expected to grow to about 3.4 M, whereas Selling General Administrative is forecasted to decline to about 74 M.

	2021	2022	2023	2024 (projected)
Gross Profit	85.4M	106.6M	107.0M	58.1M
Total Revenue	126.7M	161.7M	165.2M	92.0M

Gross Profit Total Revenue

Establishment Labs fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets	Other Stockholder Equity
Common Stock Shares Outstanding		0.85	0.57	0.64	-0.55	0.7	0.34	0.57	0.57	0.21	0.21	-0.8	0.57	0.82	0.57	0.18	-0.55	0.82	0.82	0.9	0.89	0.71	0.83	0.7	0.79	0.81
Total Assets	0.85		0.79	0.47	-0.44	0.61	0.16	0.42	0.77	0.24	0.45	-0.93	0.74	0.82	0.77	0.42	-0.28	0.82	0.98	0.87	0.96	0.88	0.9	0.84	0.91	0.9
Short Long Term Debt Total	0.57	0.79		0.38	-0.12	0.16	-0.31	-0.12	0.98	0.4	0.88	-0.92	0.93	0.48	0.98	0.79	0.11	0.48	0.81	0.56	0.64	0.97	0.87	0.89	0.75	0.89
Other Current Liab	0.64	0.47	0.38		-0.08	0.25	0.04	0.17	0.38	0.6	0.21	-0.53	0.39	0.44	0.38	0.05	-0.45	0.44	0.5	0.64	0.49	0.45	0.68	0.4	0.54	0.63
Total Current Liabilities	-0.55	-0.44	-0.12	-0.08		-0.88	-0.7	-0.87	-0.11	0.47	0.28	0.37	-0.11	-0.79	-0.11	0.21	0.76	-0.79	-0.35	-0.61	-0.62	-0.31	-0.36	-0.35	-0.41	-0.35
Total Stockholder Equity	0.7	0.61	0.16	0.25	-0.88		0.7	0.94	0.21	-0.26	-0.27	-0.5	0.25	0.86	0.22	-0.09	-0.79	0.86	0.52	0.79	0.77	0.36	0.5	0.48	0.5	0.5
Other Liab	0.34	0.16	-0.31	0.04	-0.7	0.7		0.79	-0.27	-0.2	-0.59	0.04	-0.25	0.43	-0.26	-0.52	-0.85	0.43	0.12	0.51	0.3	-0.12	0.04	0.01	0.08	0.01
Net Tangible Assets	0.57	0.42	-0.12	0.17	-0.87	0.94	0.79		-0.1	-0.38	-0.55	-0.24	-0.07	0.78	-0.09	-0.41	-0.8	0.78	0.32	0.63	0.63	0.1	0.25	0.18	0.36	0.23
Property Plant And Equipment Net	0.57	0.77	0.98	0.38	-0.11	0.21	-0.27	-0.1		0.42	0.88	-0.92	0.98	0.45	1.0	0.86	0.05	0.45	0.8	0.59	0.63	0.96	0.88	0.94	0.69	0.91
Current Deferred Revenue	0.21	0.24	0.4	0.6	0.47	-0.26	-0.2	-0.38	0.42		0.48	-0.29	0.39	-0.04	0.42	0.34	0.08	-0.04	0.29	0.27	0.05	0.33	0.42	0.28	0.27	0.39
Net Debt	0.21	0.45	0.88	0.21	0.28	-0.27	-0.59	-0.55	0.88	0.48		-0.66	0.85	0.01	0.87	0.89	0.42	0.01	0.54	0.19	0.24	0.77	0.61	0.7	0.41	0.65
Retained Earnings	-0.8	-0.93	-0.92	-0.53	0.37	-0.5	0.04	-0.24	-0.92	-0.29	-0.66		-0.91	-0.72	-0.92	-0.63	0.21	-0.72	-0.93	-0.81	-0.87	-0.97	-0.97	-0.95	-0.86	-0.98
Accounts Payable	0.57	0.74	0.93	0.39	-0.11	0.25	-0.25	-0.07	0.98	0.39	0.85	-0.91		0.41	0.99	0.88	-0.01	0.41	0.78	0.6	0.61	0.92	0.87	0.96	0.62	0.9
Cash	0.82	0.82	0.48	0.44	-0.79	0.86	0.43	0.78	0.45	-0.04	0.01	-0.72	0.41		0.45	0.03	-0.57	1.0	0.72	0.83	0.92	0.64	0.71	0.59	0.82	0.7
Non Current Assets Total	0.57	0.77	0.98	0.38	-0.11	0.22	-0.26	-0.09	1.0	0.42	0.87	-0.92	0.99	0.45		0.86	0.04	0.45	0.8	0.6	0.63	0.96	0.88	0.95	0.68	0.91
Non Currrent Assets Other	0.18	0.42	0.79	0.05	0.21	-0.09	-0.52	-0.41	0.86	0.34	0.89	-0.63	0.88	0.03	0.86		0.37	0.03	0.46	0.19	0.23	0.69	0.55	0.76	0.28	0.61
Other Assets	-0.55	-0.28	0.11	-0.45	0.76	-0.79	-0.85	-0.8	0.05	0.08	0.42	0.21	-0.01	-0.57	0.04	0.37		-0.57	-0.24	-0.69	-0.45	-0.09	-0.34	-0.23	-0.23	-0.3
Cash And Short Term Investments	0.82	0.82	0.48	0.44	-0.79	0.86	0.43	0.78	0.45	-0.04	0.01	-0.72	0.41	1.0	0.45	0.03	-0.57		0.72	0.83	0.92	0.64	0.71	0.59	0.82	0.7
Net Receivables	0.82	0.98	0.81	0.5	-0.35	0.52	0.12	0.32	0.8	0.29	0.54	-0.93	0.78	0.72	0.8	0.46	-0.24	0.72		0.85	0.92	0.9	0.91	0.86	0.88	0.91
Good Will	0.9	0.87	0.56	0.64	-0.61	0.79	0.51	0.63	0.59	0.27	0.19	-0.81	0.6	0.83	0.6	0.19	-0.69	0.83	0.85		0.9	0.72	0.87	0.77	0.77	0.85
Common Stock Total Equity	0.89	0.96	0.64	0.49	-0.62	0.77	0.3	0.63	0.63	0.05	0.24	-0.87	0.61	0.92	0.63	0.23	-0.45	0.92	0.92	0.9		0.78	0.85	0.76	0.89	0.84
Non Current Liabilities Total	0.71	0.88	0.97	0.45	-0.31	0.36	-0.12	0.1	0.96	0.33	0.77	-0.97	0.92	0.64	0.96	0.69	-0.09	0.64	0.9	0.72	0.78		0.94	0.93	0.83	0.95
Capital Surpluse	0.83	0.9	0.87	0.68	-0.36	0.5	0.04	0.25	0.88	0.42	0.61	-0.97	0.87	0.71	0.88	0.55	-0.34	0.71	0.91	0.87	0.85	0.94		0.92	0.86	1.0
Inventory	0.7	0.84	0.89	0.4	-0.35	0.48	0.01	0.18	0.94	0.28	0.7	-0.95	0.96	0.59	0.95	0.76	-0.23	0.59	0.86	0.77	0.76	0.93	0.92		0.69	0.94
Other Current Assets	0.79	0.91	0.75	0.54	-0.41	0.5	0.08	0.36	0.69	0.27	0.41	-0.86	0.62	0.82	0.68	0.28	-0.23	0.82	0.88	0.77	0.89	0.83	0.86	0.69		0.84
Other Stockholder Equity	0.81	0.9	0.89	0.63	-0.35	0.5	0.01	0.23	0.91	0.39	0.65	-0.98	0.9	0.7	0.91	0.61	-0.3	0.7	0.91	0.85	0.84	0.95	1.0	0.94	0.84

Click cells to compare fundamentals

Establishment Labs Account Relationship Matchups

Establishment Labs fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	20.5M	23.3M	24.0M	24.5M	25.6M	21.8M
Total Assets	116.5M	156.4M	139.5M	211.1M	268.6M	150.6M
Short Long Term Debt Total	48.4M	51.8M	53.8M	178.7M	192.2M	201.8M
Other Current Liab	11.8M	14.2M	16.2M	16.5M	12.8M	14.5M
Total Current Liabilities	23.2M	25.9M	31.9M	39.0M	57.2M	30.6M
Total Stockholder Equity	39.6M	75.0M	50.7M	(8.2M)	18.4M	29.4M
Other Liab	5.5M	3.8M	3.1M	1.6M	1.5M	1.4M
Net Tangible Assets	35.7M	70.3M	45.9M	(13.3M)	(15.2M)	(14.5M)
Property Plant And Equipment Net	16.4M	18.8M	20.9M	54.8M	80.6M	84.6M
Current Deferred Revenue	785K	1.2M	769K	1.7M	1.8M	1.5M
Net Debt	10.5M	(32.8M)	391K	112.3M	152.2M	159.8M
Retained Earnings	(127.1M)	(165.2M)	(206.4M)	(281.6M)	(360.1M)	(342.1M)
Accounts Payable	10.4M	9.7M	14.5M	20.0M	41.6M	43.7M
Cash	37.7M	84.5M	53.4M	66.4M	40.0M	47.6M
Non Current Assets Total	20.7M	24.1M	26.3M	61.2M	93.7M	98.4M
Non Currrent Assets Other	368K	664K	558K	1.3M	4.7M	4.9M
Other Assets	368K	664K	558K	1.3M	1.5M	785.7K
Cash And Short Term Investments	37.7M	84.5M	53.4M	66.4M	40.0M	47.6M
Net Receivables	22.8M	19.1M	24.4M	35.4M	46.9M	25.6M
Common Stock Total Equity	147.7M	213.5M	219.7M	223.6M	257.2M	156.9M
Liabilities And Stockholders Equity	116.5M	156.4M	139.5M	211.1M	268.6M	150.6M
Non Current Liabilities Total	53.7M	55.5M	56.9M	180.3M	193.1M	202.8M
Capital Surpluse	21.2M	26.7M	36.6M	49.9M	57.4M	60.3M
Inventory	28.7M	23.2M	28.4M	36.6M	79.9M	83.9M
Other Current Assets	1.3M	5.4M	7.0M	11.5M	8.0M	5.6M
Other Stockholder Equity	18.4M	23.9M	33.7M	47.1M	60.9M	63.9M
Total Liab	76.9M	81.4M	88.8M	219.2M	250.2M	262.8M
Property Plant And Equipment Gross	16.4M	18.8M	20.9M	54.8M	96.9M	101.8M
Total Current Assets	95.8M	132.3M	113.3M	149.9M	174.9M	112.4M
Accumulated Other Comprehensive Income	691K	2.9M	3.7M	2.7M	2.0M	1.5M
Non Current Liabilities Other	336K	2.3M	2.4M	175.5M	147K	139.7K
Short Term Debt	258K	948K	402K	688K	773K	734.4K
Intangible Assets	3.4M	4.1M	4.4M	4.6M	8.0M	4.6M
Common Stock	147.7M	213.5M	219.7M	223.6M	315.6M	180.7M
Property Plant Equipment	16.4M	16.2M	20.9M	51.1M	58.8M	61.7M
Long Term Debt	48.1M	49.8M	51.9M	175.5M	188.7M	198.2M
Net Invested Capital	87.8M	124.8M	102.6M	175.5M	207.1M	127.1M
Net Working Capital	72.6M	106.4M	81.4M	110.9M	117.8M	87.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Establishment Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Establishment Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Establishment Labs Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Establishment Labs Holdings Stock:

How To Invest In Establishment

Details

Is Establishment Stock a good investment?

Details

What is Establishment Labs' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.59)

Revenue Per Share

5.58

Quarterly Revenue Growth

0.045

Return On Assets

(0.12)

Return On Equity

(2.23)

The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Establishment Deferred Long Term Liab vs Accounts Payable Analysis

Deferred Long Term Liab vs Accounts Payable

Deferred Long Term Liab vs Accounts Payable Correlation Analysis

Correlation Coefficient

Deferred Long Term Liab

Accounts Payable

Establishment Labs fundamental ratios Correlations

Establishment Labs Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Establishment Labs fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Other Stockholder Equity	+ 1.0	Capital Surpluse
Non Current Assets Total	+ 0.99	Accounts Payable
Net Receivables	+ 0.98	Total Assets
Property Plant And Equipment Net	+ 0.98	Short Long Term Debt Total

Other Stockholder Equity	- 0.98	Retained Earnings
Capital Surpluse	- 0.97	Retained Earnings
Non Current Liabilities Total	- 0.97	Retained Earnings
Inventory	- 0.95	Retained Earnings
Net Receivables	- 0.93	Retained Earnings
Retained Earnings	- 0.93	Total Assets